期刊文献+

下呼吸道感染中非发酵菌耐药性分析 被引量:3

Antimicrobial resistance of non-fermentative bacilli from patients with lower respiratory tract infections
在线阅读 下载PDF
导出
摘要 目的:探讨非发酵菌所致下呼吸道感染的临床特点及细菌耐药性。方法:分析天津市区10所医院呼吸科收治的494例非发酵菌致下呼吸道感染资料。结果:所收治的494例中,社区获得性肺炎占多数。高龄、重症基础疾病、长期应用抗生素或激素、气管插管及导管留置时间过长是非发酵菌导致下呼吸道感染的危险因素。其临床表现缺乏特异性。检出非发酵菌各属细菌的比例依次为不动杆菌属(57.3%)、铜绿假单胞菌(33.5%)、嗜麦芽窄食单胞菌(4.6%)、其他假单胞菌(2.4%)和其他(2.2%)。药敏结果显示非发酵菌严重耐药,亚胺培南耐药性最低。非发酵菌对第三代头孢菌素及氨曲南、氨苄西林高度耐药。加用β内酰胺酶抑制剂的第三代头孢菌素的耐药率大大低于未加用者。结论:非发酵菌致下呼吸道感染临床表现无特异性,治疗时应根据药敏结果选择应用抗生素。 Objective: To investigate the clinical manifestations and antimicrobial resistance of non-fermentative gram-negative bacilli isolated from patients with lower respiratory tract infections. Methods: Clinical data of 494 patients with lower respiratory tract infections caused by non-fermentative bacilli in department of respiratory diseases in 10 Tianjin hospitals during 2000-2002 and bacterial resistance of these organisms were reviewed. Results: Nearly half of these 494 cases were community-acquired pneumonia. Risk factors for non-fermentative bacillus infections included advanced age, severe underlying diseases, long term use of broad-spectrum antibiotics or adrenal cortical hormone, endotracheal intubation and long term indwelling catheter. It's clinical features were lack of specificity. Non-fermentative gram-negative bacillus isolates consisted of 57. 3% of Acinetobacter spp. , 33. 5% of Pseudomonas aeruginosa, 4. 6% of Stenotrophomonas maltophilia , 2. 4% of other Pseudomonas spp. and 2. 2% of others. The antimicrobial susceptibility testing results showed that non-fermentative bacilli were highly resistant to commonly used antimicrobials including ampicillin, third generation cephalosporins and aztreonam. The resistance rate to imipenem was the lowest among the tested antibiotics, while the resistance rate cefoperazone-sulbactam was significantly lower than cefopera zone alone. Conclusions: The clinical features of lower respiratory tract infections caused by non-fermentative bacilli are lack of specificity. Antibiotics should be chosen according to antibiotic susceptibility testing results.
出处 《中国抗感染化疗杂志》 2004年第4期216-218,共3页 Chinese Journal of Infection and Chemotherapy
关键词 非发酵菌 下呼吸道感染 耐药性 Non-fermentative bacilli Lower respiratory tract infections Antimicrobial resistance
  • 相关文献

参考文献4

二级参考文献24

  • 1中华医学会呼吸病学会.医院内获得性支气管-肺感染诊断标准[J].中华结核和呼吸杂志,1990,13:372-372.
  • 2全国医院感染监控中心,中华结核和呼吸杂志,1990年,13卷,6期,372页
  • 3王枢群,医院感染学,1990年,337页
  • 4Fiett J,Palucha A,Miaczynynska B,et al.A novel complex mutant beta-lactamase TEM-68, identified in a Klebsiella pneumoniae isolate from an outbreak of extended-spectrum beta-lactamase-produc-ing Klebsiella. Antimicrobial Agents and Chemotherapy . 2000
  • 5Westeon G,Blazquez J,Baquero F,et al.Structure-based enhance-ment of boronic acid-based inhibitors of AmpC beta-lactamase. Journal of Medicinal Chemistry . 1998
  • 6Hiramatsu K,Hanaki H,Ino T,et al.Methicillin-resistant staphylo-coccus aureus clinical strain with reduced vancomycin susceptibility. Journal of Antimicrobial Chemotherapy . 1997
  • 7Wang SS,Na TK,Yan WC,et al.Bacteremia due to Staphylococcus aureus with reduced susceptibility to vancomycin. Daign Micro-biol Infec Dis . 2000
  • 8李显志,张丽,王浴生.细菌多重抗生素耐药性及其分子生物学机制——以大肠杆菌和铜绿假单胞菌为例[J].国外医药(抗生素分册),1998,19(1):34-35. 被引量:19
  • 9凌保东,雷军.MRSA耐药基因与辅助基因[J].国外医药(抗生素分册),1999,20(1):24-27. 被引量:7
  • 10夏培元.耐甲氧西林金黄色葡萄球菌的耐药机制及其治疗药物的研究进展[J].国外医药(抗生素分册),1999,20(4):178-180. 被引量:29

共引文献166

同被引文献29

  • 1齐永志,府伟灵,张晓兵.非发酵菌的分离鉴定和耐药性分析[J].中华医院感染学杂志,2006,16(11):1286-1288. 被引量:18
  • 2National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial testing[S]. NCCLS,1999:36.
  • 3Lionel A M,Richard G W,Anzueto A. Infectious diseases so-ciety ofAmerican thoracic society consensus guidelines on the management of community-acquired pneumonia in adults[J].Clinical Infectious Diseases,2007.S27-S72.
  • 4El-solh A A,Aquilina A T,DhiUon R S. Impact of invasive srategyon management of an timicrobial treatment failure in in-stitutionalized older people with severe pneumonia[J].American Journal of Respiratory and Critical Care Medicine,2002,(08):1038-1043.
  • 5Low D E,Mazzul i T,Marrie T. Progressive and nonresolving pneu-monia[J].Current Opinion in Pulmonary Medicine,2005.247-252.
  • 6Akbari J G,Varma P K,Neema P K. Clinical profile and surgi-cal outcome for pulmonary aspergil oma:a single center experi-ence[J].Annals of Thoracic Surgery,2005.1067-1072.
  • 7Menendez R,Torres A,Zalaeain R. Risk factors of treatment failure in communiy acquired pneumonia implications for disease outcome[J].Thorax,2004,(11):960-965.
  • 8Ferretti G R,Jankowski A,Rodière M. CT-guided Biopsy of Nonresolving Focal Air Space Consolidation[J].Journal of Thoracic Imaging,2008,(01):7-12.
  • 9Menendez R,Perplna M,Torres A. Evaluatlon ofnonresloving and progressive pneumonia[J].Seminars in Respiratory Infections,2003.103-111.
  • 10Clinical and Laboratory Standards Institue Performance standards for antimicrobial susceptibility testing [S].M 100, CLSI,2009.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部